Wikidata

(Q84894126)

English

KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy

scientific article published on 02 September 2011

In more languages

Statements

title
KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21894049
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21894049%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q84894126&oldid=1587518344"